Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marmé D, Martiny-Baron G
Institute of Molecular Medicine, Tumor Biology Center, D-79106 Freiburg, Germany.
J Biol Chem. 1997 Apr 18;272(16):10382-8. doi: 10.1074/jbc.272.16.10382.
The vascular endothelial growth factor (VEGF) receptor FLT-1 has been shown to be involved in vasculogenesis and angiogenesis. The receptor is characterized by seven Ig-like loops within the extracellular domain. Upon VEGF binding FLT-1 becomes phosphorylated, which has been thought to be preceded by receptor dimerization. To further investigate high affinity binding of VEGF to FLT-1 and ligand-induced receptor dimerization, we expressed in Sf9 cells the entire extracellular domain comprising all seven Ig-like loops: sFLT-1(7) and several truncated mutants consisting of loop one, one and two, one to three, one to four, and one to five. The corresponding proteins, named sFLT-1(1), (2), (3), (4), and (5) were purified. Only mutants sFLT-1(3) to (7) were able to bind 125I-VEGF with high affinity. No binding of VEGF was observed with sFLT-1(1) and sFLT-1(2), indicating that the first three Ig-like loops are involved in high affinity binding of VEGF. The binding of VEGF to sFLT-1(3) could be competed with placenta growth factor (PlGF), a VEGF-related ligand, suggesting that high affinity binding of VEGF and PlGF is mediated by the same or closely related contact sites on sFLT-1. Deglycosylation of the sFLT-1(3), (4), (5), and (7) did not abolish VEGF binding. Furthermore, unglycosylated sFLT-1(3), expressed in Escherichia coli, was able to bind VEGF with similar affinity as sFLT-1(3) or sFLT-1(7), both expressed in Sf9 cells. This indicates that receptor glycosylation is not essential for high affinity binding. Dimerization of the extracellular domains of FLT-1 upon addition of VEGF was detected with all mutants containing the Ig-like loop four. Although sFLT-1(3) was able to bind VEGF, dimerization of this mutant was inefficient, indicating that sites on Ig-like loop four are essential to stabilize receptor dimers.
血管内皮生长因子(VEGF)受体FLT-1已被证明参与血管生成和血管新生。该受体的特征是细胞外结构域内有七个免疫球蛋白(Ig)样环。VEGF与FLT-1结合后,FLT-1会发生磷酸化,一般认为在此之前受体先发生二聚化。为了进一步研究VEGF与FLT-1的高亲和力结合以及配体诱导的受体二聚化,我们在Sf9细胞中表达了包含所有七个Ig样环的完整细胞外结构域:sFLT-1(7),以及由环1、环1和环2、环1至环3、环1至环4和环1至环5组成的几个截短突变体。纯化了相应的蛋白质,分别命名为sFLT-1(1)、(2)、(3)、(4)和(5)。只有突变体sFLT-1(3)至(7)能够以高亲和力结合125I-VEGF。未观察到sFLT-1(1)和sFLT-1(2)与VEGF结合,这表明前三个Ig样环参与了VEGF的高亲和力结合。VEGF与sFLT-1(3)的结合可被胎盘生长因子(PlGF,一种与VEGF相关的配体)竞争,这表明VEGF和PlGF的高亲和力结合是由sFLT-1上相同或密切相关的接触位点介导的。sFLT-1(3)、(4)、(5)和(7)的去糖基化并未消除VEGF结合。此外,在大肠杆菌中表达的未糖基化sFLT-1(3)能够以与在Sf9细胞中表达的sFLT-1(3)或sFLT-1(7)相似的亲和力结合VEGF。这表明受体糖基化对于高亲和力结合并非必不可少。在添加VEGF后,所有含有Ig样环4的突变体都检测到了FLT-1细胞外结构域的二聚化。尽管sFLT-1(3)能够结合VEGF,但该突变体的二聚化效率较低,这表明Ig样环4上的位点对于稳定受体二聚体至关重要。